牛牛AI助理已提取核心訊息
On August 27, 2024, Aclarion, Inc., a Delaware-incorporated company, announced the entry into a subscription agreement with certain accredited investors. Under this agreement, Aclarion agreed to issue and sell 1,000,000 shares of common stock at $0.29 per share, resulting in gross proceeds of $290,000. The shares were offered at-the-market under Nasdaq rules following the Company's Form 1-A Offering Statement, which was filed with the SEC on June 11, 2024, and qualified on June 24, 2024. Additionally, Aclarion entered into a warrant purchase agreement with the investors, issuing warrants to purchase up to 400,000 shares of common stock, exercisable from February 27, 2025, with a five-year term and an initial exercise price of $0.29 per share. These transactions were not brokered, and no fees or commissions will be paid. The company has the option to raise additional proceeds up to approximately $29.39 million under the same terms in the future. The securities were sold without registration under the Securities Act of 1933, in reliance on exemptions provided by Section 4(a)(2) for the Warrants and Regulation A for the Shares.
On August 27, 2024, Aclarion, Inc., a Delaware-incorporated company, announced the entry into a subscription agreement with certain accredited investors. Under this agreement, Aclarion agreed to issue and sell 1,000,000 shares of common stock at $0.29 per share, resulting in gross proceeds of $290,000. The shares were offered at-the-market under Nasdaq rules following the Company's Form 1-A Offering Statement, which was filed with the SEC on June 11, 2024, and qualified on June 24, 2024. Additionally, Aclarion entered into a warrant purchase agreement with the investors, issuing warrants to purchase up to 400,000 shares of common stock, exercisable from February 27, 2025, with a five-year term and an initial exercise price of $0.29 per share. These transactions were not brokered, and no fees or commissions will be paid. The company has the option to raise additional proceeds up to approximately $29.39 million under the same terms in the future. The securities were sold without registration under the Securities Act of 1933, in reliance on exemptions provided by Section 4(a)(2) for the Warrants and Regulation A for the Shares.
2024年8月27日，總部位於特拉華州的Aclarion, Inc.宣佈與某些合格投資者簽訂了認購協議。根據該協議，Aclarion同意以每股0.29美元的價格發行和賣出1,000,000股普通股，募集總額爲290,000美元。這些股票根據納斯達克規則在公司於2024年6月11日向SEC提交的1-A表格募集說明書下以市價發行，於2024年6月24日獲得資格。此外，Aclarion還與投資者簽訂了認股權購買協議，發行認股權以購買高達400,000股普通股，自2025年2月27日起行使，爲期五年，初始行使價格爲每股0.29美元。這些交易未經經紀人介紹，不會支付任何費用或佣金。公司有權在未來以相同條款最多募集約2939萬美元的額外資金。這些證券在未經1933年證券法註冊的情況下出售，依賴於擔保4(a)(2)提供的認股權豁免和按照股份規定A提供的普通股規定。
2024年8月27日，總部位於特拉華州的Aclarion, Inc.宣佈與某些合格投資者簽訂了認購協議。根據該協議，Aclarion同意以每股0.29美元的價格發行和賣出1,000,000股普通股，募集總額爲290,000美元。這些股票根據納斯達克規則在公司於2024年6月11日向SEC提交的1-A表格募集說明書下以市價發行，於2024年6月24日獲得資格。此外，Aclarion還與投資者簽訂了認股權購買協議，發行認股權以購買高達400,000股普通股，自2025年2月27日起行使，爲期五年，初始行使價格爲每股0.29美元。這些交易未經經紀人介紹，不會支付任何費用或佣金。公司有權在未來以相同條款最多募集約2939萬美元的額外資金。這些證券在未經1933年證券法註冊的情況下出售，依賴於擔保4(a)(2)提供的認股權豁免和按照股份規定A提供的普通股規定。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了